Omkar Pharmachem Ltd
Incorporated in 1995, Omkar Pharmachem Ltd manufactures chemicals used in pharmaceuticals.
- Market Cap ₹ 28.6 Cr.
 - Current Price ₹ 28.3
 - High / Low ₹ 30.1 / 25.5
 - Stock P/E 159
 - Book Value ₹ 9.35
 - Dividend Yield 0.00 %
 - ROCE 3.04 %
 - ROE 2.14 %
 - Face Value ₹ 10.0
 
Pros
- Company has reduced debt.
 - Company is almost debt free.
 
Cons
- Stock is trading at 3.03 times its book value
 - Promoter holding is low: 0.03%
 - Company has a low return on equity of 2.15% over last 3 years.
 
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.27 | 0.54 | 0.54 | 0.54 | 0.54 | 0.56 | |
| 0.07 | 0.06 | 0.12 | 0.22 | 0.24 | 0.38 | 0.26 | 0.24 | 0.27 | 0.22 | 0.25 | 0.24 | 0.27 | |
| Operating Profit | 0.00 | -0.06 | -0.12 | -0.22 | -0.24 | -0.38 | -0.21 | 0.03 | 0.27 | 0.32 | 0.29 | 0.30 | 0.29 | 
| OPM % | 0.00% | -420.00% | 11.11% | 50.00% | 59.26% | 53.70% | 55.56% | 51.79% | |||||
| 0.00 | 0.00 | 0.00 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 | 0.03 | 0.02 | 0.02 | 
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 
| Profit before tax | 0.00 | -0.06 | -0.12 | 0.27 | -0.25 | -0.42 | -0.26 | -0.03 | 0.21 | 0.27 | 0.26 | 0.27 | 0.27 | 
| Tax % | 0.00% | 0.00% | 18.52% | 0.00% | 0.00% | 0.00% | -866.67% | 14.29% | 25.93% | 23.08% | 25.93% | ||
| 0.00 | -0.06 | -0.12 | 0.22 | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 | 0.18 | |
| EPS in Rs | 0.00 | -0.06 | -0.12 | 0.22 | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 | 0.18 | 
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % | 
| 5 Years: | 61% | 
| 3 Years: | 0% | 
| TTM: | 0% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% | 
| 5 Years: | 23% | 
| 3 Years: | 4% | 
| TTM: | -5% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | % | 
| 5 Years: | % | 
| 3 Years: | 6% | 
| 1 Year: | 5% | 
| Return on Equity | |
|---|---|
| 10 Years: | 0% | 
| 5 Years: | 2% | 
| 3 Years: | 2% | 
| Last Year: | 2% | 
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 
| Reserves | -0.75 | -0.81 | -0.93 | -0.71 | -0.96 | -1.38 | -1.64 | -1.42 | -1.24 | -1.04 | -0.85 | -0.65 | 
| 0.01 | 0.01 | 0.00 | 0.00 | 0.24 | 0.58 | 0.87 | 0.90 | 0.93 | 0.62 | 0.30 | 0.12 | |
| 0.11 | 0.13 | 0.57 | 0.06 | 0.04 | 0.05 | 0.06 | 0.08 | 0.06 | 0.07 | 0.07 | 0.05 | |
| Total Liabilities | 9.45 | 9.41 | 9.72 | 9.43 | 9.40 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.60 | 9.60 | 
| 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| Investments | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 
| 0.14 | 0.10 | 0.41 | 0.13 | 0.09 | 0.03 | 0.07 | 0.34 | 0.52 | 0.43 | 0.29 | 0.29 | |
| Total Assets | 9.45 | 9.41 | 9.72 | 9.43 | 9.40 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.60 | 9.60 | 
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | -0.05 | 0.34 | -0.77 | -0.25 | -0.30 | -0.21 | 0.02 | 0.20 | 0.28 | 0.30 | 0.24 | |
| 0.00 | 0.00 | 0.00 | 0.49 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 | |
| 0.00 | 0.00 | -0.01 | 0.01 | 0.23 | 0.30 | 0.24 | -0.02 | -0.03 | -0.35 | -0.35 | -0.20 | |
| Net Cash Flow | 0.01 | -0.05 | 0.33 | -0.28 | -0.03 | 0.00 | 0.02 | 0.00 | 0.17 | -0.08 | -0.06 | 0.04 | 
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365.00 | 146.00 | 40.56 | 54.07 | 87.87 | 33.80 | 67.59 | |||||
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 365.00 | 146.00 | 40.56 | 54.07 | 87.87 | 33.80 | 67.59 | |||||
| Working Capital Days | -52.14 | -6,570.00 | -1,270.74 | -608.33 | -378.52 | -162.22 | -6.76 | |||||
| ROCE % | 0.00% | -0.64% | -1.30% | -2.27% | -2.56% | -4.08% | -2.26% | 0.32% | 2.79% | 3.29% | 3.02% | 3.04% | 
Documents
Announcements
- 
        
          Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests For The Month Of September, 2025
          
            28 Oct - SEBI special-window re-lodgement report for September 2025: zero requests received, processed, approved, or rejected.
 - 
        
          Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
          
            15 Oct - Dear Sir, Please find Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter ended 30.09.2025.
 - 
        
          Closure of Trading Window
          
            27 Sep - Trading window closed from 1 Oct 2025 until 48 hours after unaudited results for quarter/half-year ended 30 Sep 2025.
 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 25 Sep
 - Shareholder Meeting / Postal Ballot-Outcome of AGM 24 Sep
 
Annual reports
- 
    
      Financial Year 2025
      from bse
 - 
    
      Financial Year 2024
      from bse
 - 
    
      Financial Year 2023
      from bse
 - 
    
      Financial Year 2022
      from bse
 - 
    
      Financial Year 2021
      from bse
 - 
    
      Financial Year 2020
      from bse
 - 
    
      Financial Year 2019
      from bse
 - 
    
      Financial Year 2018
      from bse
 - 
    
      Financial Year 2017
      from bse
 - 
    
      Financial Year 2016
      from bse
 - 
    
      Financial Year 2015
      from bse
 - 
    
      Financial Year 2014
      from bse
 - 
    
      Financial Year 2013
      from bse
 - 
    
      Financial Year 2012
      from bse
 - 
    
      Financial Year 2011
      from bse
 
Product Profile:[1][2]
a) Sodium bi-sulphite
b) Sodium meta bi-sulphite
c) Sodium sulphite
d) Sulphur
e) Specialty chemicals
f) Ciba specialty chemicals
g) Organic chemicals